Calliditas Therapeutics to Unveil Key Findings at Nephrology Congress Calliditas Therapeutics AB will showcase pivotal findings from the Phase 3 NefIgArd trial at the World Congress of Nephrology, shedding light on advances in IgA nephropathy treatment.

Calliditas Therapeutics to Unveil Key Findings at Nephrology Congress #Japan #Yokohama #Calliditas #TARPEYO #NefIgArd